Higgins et al. used BEAMing to detect PIK3CA mutations in breast cancer patients, and found out the mutations present in approximately 30% of the patients, the results for plasma ctDNA showed 100% concordance to archival tumor tissue when tissue and blood samples were obtained simultaneously [56]. The gene discussed is PIK3CA; the disease is breast carcinoma.